openPR Logo
Press release

Biopharma PEG to Exhibit at BIO 2024 in San Diego

05-21-2024 11:50 AM CET | Chemicals & Materials

Press release from: Biopharma PEG Scientific Inc

Biopharma PEG, a leading provider of advanced polyethylene glycol (PEG) derivatives, is excited to announce its participation in the BIO International Convention 2024, scheduled to take place from June 3-6, 2024, at the San Diego Convention Center. Attendees are invited to visit Biopharma PEG at Booth 5102 to explore their comprehensive range of PEG products tailored for the biopharmaceutical industry.
As an industry frontrunner, Biopharma PEG specializes in the production of high-quality monodispersed, polydispersed, and multi-arm PEG derivatives. These products are crucial in a variety of applications including Antibody-Drug Conjugates (ADCs), Proteolysis Targeting Chimeras (PROTACs), Lipid Nanoparticle (LNP) delivery systems, hydrogels, and 3D printing.
"We are honored to participate in BIO 2024, a premier event that brings together top innovators and thought leaders in biotechnology," said Sonia, marketing director of Biopharma PEG. "Our cutting-edge PEG derivatives are designed to meet the rigorous demands of modern biopharmaceutical applications, and we are eager to showcase how our solutions can enhance drug development and delivery."
Biopharma PEG's offerings include:
Monodispersed PEGs: Ensuring uniform molecular weight for precise and reliable performance.
Polydispersed PEGs: Providing a spectrum of molecular weights to meet diverse application requirements.
Multi-arm PEGs: Featuring multiple reactive sites to enhance the functionality and complexity of drug formulations.
Visitors to Booth 5102 will have the opportunity to engage with Biopharma PEG's technical experts, who will be available to discuss specific project needs and demonstrate how their products can support various stages of research and development.
BIO 2024 promises to gather thousands of professionals from the global biotech and pharmaceutical sectors, offering unparalleled opportunities for networking, learning, and collaboration. Biopharma PEG is poised to leverage this platform to connect with potential partners and showcase their innovative solutions.
For further information about Biopharma PEG and their presence at BIO 2024, please visit https://www.biochempeg.com/ or contact sales@biochempeg.com.

CONTACT
Biopharma PEG Scientific Inc.
108 Water Street, Suite 4D, Watertown, MA 02472, USA
TEL: 1-857-928-2050 / 1-857-366-6766
Fax: 617-206-9595
Email: sales@biochempeg.com

Biopharma PEG is a premier supplier of PEG derivatives, dedicated to supporting the pharmaceutical, biotechnology, and medical device industries with high-quality products that enhance the performance and delivery of therapeutic agents. For more information, visit https://www.biochempeg.com/.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Biopharma PEG to Exhibit at BIO 2024 in San Diego here

News-ID: 3502954 • Views:

More Releases from Biopharma PEG Scientific Inc

BIOPHARMA PEG Receives FDA DMF Listings for Two Key PEG Derivatives
BIOPHARMA PEG, a leading developer and supplier of high-purity polyethylene glycol (PEG) derivatives, today announced that two of its proprietary products-mPEG-pALD 20K and HZ-PEG-HZ (1K)-have successfully passed FDA review and are now listed in the U.S. Drug Master File (DMF) database. mPEG-pALD (20K) - DMF No. 040600 HZ-PEG-HZ (1K) - DMF No. 041864 These new listings mark a significant step in BIOPHARMA PEG's ongoing efforts to provide regulatory-ready, high-quality PEG solutions to the
Monodispersed PEG Linkers Enhance Antibody-Drug Conjugates (ADCs)
Antibody-drug conjugates (ADCs) combine potent small-molecule drugs with monoclonal antibodies for targeted cancer therapy. A major challenge is loading enough drug onto each antibody without compromising solubility or circulation time. Introducing polyethylene glycol (PEG) linkers between the antibody and drug payload can address this. PEG is hydrophilic, biologically inert, and FDA‐recognized as safe. As a flexible spacer, PEG "shields" the hydrophobic drug, greatly improving ADC solubility and stability. In fact,
Biopharma PEG Scientific Inc. to Showcase Comprehensive PEG Derivative Portfolio at TIDES USA 2025
Biopharma PEG Scientific Inc. to Showcase Comprehensive PEG Derivative Portfolio …
Biopharma PEG Scientific Inc., a leading provider of high-quality polyethylene glycol (PEG) derivatives, today announced its participation in TIDES USA 2025, taking place from May 19 - 22, 2025, at the Manchester Grand Hyatt San Diego. Attendees are invited to visit Biopharma PEG at Booth #913 to explore their extensive range of GMP-grade PEG products and discuss how these solutions can advance their research and development efforts. Biopharma PEG offers a
BIOPHARMA PEG Showcases DSPE-PEG-Mannose: A Cutting-Edge Polymer for Drug Delive …
Watertown, MA - March 24, 2025 - Biopharma PEG, a leading supplier of high-quality polyethylene glycol (PEG) derivatives, highlights its innovative product DSPE-PEG-Mannose, an advanced biomedical polymer with significant potential in drug delivery, tumor-targeted therapy, tissue recognition, and adhesion. Structural Advantages of DSPE-PEG-Mannose DSPE-PEG-Mannose is composed of three key components that enable its diverse applications: DSPE (1,2-Distearoyl-sn-glycero-3-phosphoethanolamine): A phospholipid with amphiphilic properties, forming stable micelles in aqueous solutions. PEG (Polyethylene Glycol): A biocompatible polymer

All 5 Releases


More Releases for BIO

Human Plasma Products Market 2023: Industry Future Trends | Takeda, CSL, Grifols …
The Human Plasma Products market research report is proficient and top to bottom research by specialists on the current state of the industry. This statistical surveying report gives the most up to date industry information and industry future patterns, enabling you to distinguish the items and end clients driving income development and benefit. It centres around the real drivers and restrictions for the key players and present challenge status with
Gene Therapy Products Market | Advantagene, Avalanche Bio, Bluebird Bio, Cellado …
The global gene therapy products market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the gene therapy products market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants. From the perspective of market dynamics, this report explores the factors driving the growth
Bio-based Polymethyl Methacrylate (Bio-PMMA) Market 2023 | Detailed Report
The Bio-based Polymethyl Methacrylate (Bio-PMMA) report compiles the market information depending upon market development and growth factors, optimizing the growth path. In addition, it highlights the strategies and market share of the leading vendors in the particular market. The report follows a robust research methodology model that helps to make informed decisions. It obtains both qualitative and quantitative market information supported by primary research. The Bio-based Polymethyl Methacrylate (Bio-PMMA) research report
Bio Pharma Buffer Market – A comprehensive study by Key Players: Bio-Rad, Lonz …
Latest Market intelligence report released by HTF MI with title "COVID-19 Outbreak-Global Bio Pharma Buffer Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020" is designed covering micro level of analysis by manufacturers and key business segments. The COVID-19 Outbreak-Global Bio Pharma Buffer Market survey analysis offers energetic visions to conclude and study market size, market hopes, and competitive surroundings. The research is derived through primary and secondary
IVIG Market Anticipated a Noteworthy CAGR during 2019-2024 & Companies Included …
A report added to the rich database of Qurate Business Intelligence, titled “World IVIG Market by Product Type, Players and Regions - Forecast to 2024”, provides a 360-degree overview of the Global market. Approximations associated with the market values over the forecast period are based on empirical research and data collected through both primary and secondary sources. The authentic processes followed to exhibit various aspects of the market makes the
Green & Bio-based Solvents Market Analysis, Demand, & Opportunities till 2023 | …
A latest research report titled as “Green & Bio-based Solvents Market for Paints & Coatings, Printing Inks, Commercial & Domestic Cleaning, Adhesives & Sealants, Pharmaceutical, Cosmetics, and Other Applications - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023” has been recently added to the vast portfolio of Market Research Reports Search Engine (MRRSE) online research offerings. This report is a professional and in-depth analysis on the